Welch & Forbes LLC Buys 43,475 Shares of Xylem Inc. (NYSE:XYL)

Welch & Forbes LLC increased its position in Xylem Inc. (NYSE:XYL) by 450.1% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 53,133 shares of the industrial products company’s stock after purchasing an additional 43,475 shares during the quarter. Welch & Forbes LLC’s holdings in Xylem were worth $6,076,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently made changes to their positions in the company. Bruce G. Allen Investments LLC purchased a new stake in Xylem during the fourth quarter valued at $27,000. NBC Securities Inc. purchased a new position in shares of Xylem in the third quarter worth approximately $38,000. Orion Capital Management LLC bought a new stake in Xylem during the third quarter valued at approximately $48,000. Spire Wealth Management increased its holdings in Xylem by 370.9% during the fourth quarter. Spire Wealth Management now owns 485 shares of the industrial products company’s stock valued at $54,000 after buying an additional 382 shares during the last quarter. Finally, Cary Street Partners Investment Advisory LLC grew its position in shares of Xylem by 117.0% during the 3rd quarter. Cary Street Partners Investment Advisory LLC now owns 716 shares of the industrial products company’s stock valued at $65,000 after acquiring an additional 386 shares during the period. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Insider Buying and Selling

In other Xylem news, SVP Franz Cerwinka sold 2,408 shares of the stock in a transaction on Thursday, February 8th. The stock was sold at an average price of $121.79, for a total value of $293,270.32. Following the sale, the senior vice president now owns 11,750 shares in the company, valued at $1,431,032.50. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In related news, CAO Geri-Michelle Mcshane sold 1,000 shares of the firm’s stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $122.89, for a total value of $122,890.00. Following the completion of the transaction, the chief accounting officer now owns 2,935 shares in the company, valued at approximately $360,682.15. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Franz Cerwinka sold 2,408 shares of the firm’s stock in a transaction dated Thursday, February 8th. The stock was sold at an average price of $121.79, for a total value of $293,270.32. Following the completion of the transaction, the senior vice president now owns 11,750 shares of the company’s stock, valued at $1,431,032.50. The disclosure for this sale can be found here. 0.27% of the stock is owned by corporate insiders.

Xylem Trading Up 0.6 %

XYL traded up $0.83 on Tuesday, hitting $140.03. The company had a trading volume of 1,273,273 shares, compared to its average volume of 1,186,048. Xylem Inc. has a 12-month low of $87.59 and a 12-month high of $141.25. The company has a quick ratio of 1.22, a current ratio of 1.67 and a debt-to-equity ratio of 0.19. The business’s fifty day simple moving average is $128.91 and its 200 day simple moving average is $115.87. The company has a market cap of $33.95 billion, a PE ratio of 49.54, a PEG ratio of 2.67 and a beta of 1.08.

Xylem (NYSE:XYL) last announced its earnings results on Thursday, May 2nd. The industrial products company reported $0.90 earnings per share for the quarter, beating the consensus estimate of $0.84 by $0.06. Xylem had a net margin of 8.34% and a return on equity of 8.95%. The business had revenue of $2.03 billion for the quarter, compared to the consensus estimate of $2 billion. During the same quarter in the prior year, the firm posted $0.72 earnings per share. The business’s revenue for the quarter was up 40.4% on a year-over-year basis. Equities research analysts expect that Xylem Inc. will post 4.24 EPS for the current year.

Analysts Set New Price Targets

Several analysts have issued reports on the company. Royal Bank of Canada boosted their price target on Xylem from $157.00 to $162.00 and gave the company an “outperform” rating in a report on Friday. Oppenheimer raised their target price on shares of Xylem from $142.00 to $147.00 and gave the stock an “outperform” rating in a research note on Friday. Stifel Nicolaus increased their price objective on shares of Xylem from $136.00 to $150.00 and gave the stock a “buy” rating in a research note on Wednesday, February 7th. BNP Paribas started coverage on shares of Xylem in a research note on Tuesday, March 12th. They set an “outperform” rating and a $150.00 target price on the stock. Finally, Citigroup boosted their price target on Xylem from $126.00 to $139.00 and gave the stock a “neutral” rating in a report on Monday, April 8th. Five equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $140.70.

Xylem Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.